Thus, while IL-18 dysregulation has been observed in AD patients in association with severity of symptoms and correlated to increased Aβ production in vitro (59–62), a protective function has been also reported in IL-18-deficient mice in both physiological (63) and AD-like conditions (64). This evidence concerns the gene IL18 and Alzheimer disease.